Board of Directors
(click on a name to jump to a bio)
Dan Broderick, President
Dan is a senior fellow at BioGenerator - a not for profit business accelerator and seed fund - and a venture partner at Prolog Ventures. Before joining BioGenerator in 2009, he was managing director at Prolog Ventures in St. Louis. Prior to that Dan spent seven years with Mason Wells Biomedical Fund as a managing director, where he was responsible for all aspects of investment activities. While at Mason Wells, Dan served as a member of the board of directors of several portfolio companies including Gala Biotech, Mezzia, OpGen, Deltanoid Pharmaceuticals and ZyStor Therapeutics.
Prior to Mason Wells, Dan spent 18 years at Mayo Clinic in Rochester, Minnesota, where for 12 years he served as director of the office of technology commercialization. He played a key role in the launch of Mayo Clinic's $25 million venture investing program. He co-founded and served on the board of directors of IntraTherapuetics, Inc., CNSoftware and Medintell, Inc. In 1994, Dan was honored with an appointment to the Staff of Mayo Clinic.
Dan is actively involved in the venture capital community on a regional and national level. He served on the board of directors of the National Venture Capital Association (NVCA). He has testified before the U.S. Congress on behalf of the NVCA; works on a number of NVCA committees, and chaired the NVCA research committee. Dan is the founder and president of the Mid-America Healthcare Investor Network (MHIN), an organization designed to promote venture investing in mid-America.
Dan received a Bachelor's degree in Biology from Iowa State University in 1982. Dan enjoys life in St. Louis with his wife, Nancy, and has three grown children, Andrew, Sara and Kelly. He also enjoys fishing, woodworking and renaissance art.